Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMID 8262968)

Published in J Biol Chem on December 25, 1993

Authors

A Peña1, C D Reddy, S Wu, N J Hickok, E P Reddy, G Yumet, D R Soprano, K J Soprano

Author Affiliations

1: Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

Articles citing this

c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol (1999) 8.17

Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev (2001) 6.36

A perspective of polyamine metabolism. Biochem J (2003) 3.24

An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol (1995) 2.08

Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle (2008) 1.98

Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol Cell Biol (1997) 1.92

HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol (2000) 1.71

Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol (1997) 1.37

Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1. Nucleic Acids Res (1997) 1.01

Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol Cell Biol (1997) 0.91

Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine. Biochem J (2003) 0.91

Characterization of cell-specific modulatory element in the murine ornithine decarboxylase promoter. Biochem J (1996) 0.90

Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. Biochem J (1997) 0.87

Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation. Mol Cell Biol (1995) 0.87

Specific requirement of putrescine for the mitogenic action of juvenile hormone on adult insect neuroblasts. Proc Natl Acad Sci U S A (1997) 0.85

The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Mol Cell Biol (1999) 0.84

DFMO: targeted risk reduction therapy for colorectal neoplasia. Best Pract Res Clin Gastroenterol (2011) 0.84

Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. J Med Chem (2007) 0.81

Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate. Mol Med (1995) 0.80

A role for c-myc in chemically induced renal-cell death. Mol Cell Biol (1997) 0.80

Molecular cloning and characterization of ornithine decarboxylase cDNA of the nematode Panagrellus redivivus. Biochem J (1995) 0.78

Panagrellus redivivus ornithine decarboxylase: structure of the gene, expression in Escherichia coli and characterization of the recombinant protein. Biochem J (1996) 0.78

A minimal regulatory region maintains constitutive expression of the max gene. Mol Cell Biol (1997) 0.76

Articles by these authors

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet (1999) 8.53

Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80

Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol (2001) 5.57

Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature (1982) 5.11

JNK signaling in apoptosis. Oncogene (2008) 4.72

A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. Physiol Genomics (2001) 4.50

Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature (1983) 4.34

Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci U S A (1983) 4.32

Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc. Proc Natl Acad Sci U S A (1983) 4.06

Stress: a factor to be considered in heterotrophic microorganism enumeration from aquatic environments. Appl Microbiol (1974) 4.03

Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene (1995) 3.96

Nucleotide sequence analysis of the proviral genome of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A (1983) 3.43

The myb gene family in cell growth, differentiation and apoptosis. Oncogene (1999) 3.28

Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science (1982) 3.12

HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science (1986) 3.06

Gene product of v-fgr onc: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase. Science (1984) 3.06

Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A (2008) 2.98

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science (1984) 2.97

Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A (2000) 2.96

Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci U S A (1983) 2.95

Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.93

Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J (1993) 2.80

Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature (1991) 2.57

Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med (1990) 2.56

Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science (1981) 2.51

Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line. Proc Natl Acad Sci U S A (1986) 2.43

DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science (1983) 2.40

Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA. Proc Natl Acad Sci U S A (1981) 2.34

Intracellular signalling: PDK1--a kinase at the hub of things. Curr Biol (1999) 2.31

Scaffold proteins of MAP-kinase modules. Oncogene (2007) 2.30

Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science (1984) 2.28

Liver stem cells and hepatocellular carcinoma. Hepatology (2009) 2.27

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest (1999) 2.21

Modulation of life and death by the TNF receptor superfamily. Oncogene (1998) 2.18

Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1983) 2.16

Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation. Nature (1986) 2.15

Hematopoietic cytokine receptor signaling. Oncogene (2007) 2.13

Janus kinases: components of multiple signaling pathways. Oncogene (2000) 2.02

Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. Nucleic Acids Res (1985) 2.01

Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science (2000) 2.01

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology (1998) 1.98

Identification of the leukemogenic protein of avian myeloblastosis virus and of its normal cellular homologue. Proc Natl Acad Sci U S A (1983) 1.97

Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene (1996) 1.96

Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. Mol Cell Biol (1982) 1.94

Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science (1983) 1.94

Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol (1998) 1.91

Spontaneous activation of a human proto-oncogene. Proc Natl Acad Sci U S A (1983) 1.90

Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol (1994) 1.88

HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients. Cell (1985) 1.87

Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions. Proc Natl Acad Sci U S A (1990) 1.84

Mutational analysis of simian virus 40 T antigen: stimulation of cellular DNA synthesis and activation of rRNA genes by mutants with deletions in the T-antigen gene. Mol Cell Biol (1983) 1.81

Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology (1986) 1.78

Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells. Proc Natl Acad Sci U S A (1982) 1.72

Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature (1997) 1.69

Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol (1998) 1.67

Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J (2001) 1.67

Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor. Cell (1984) 1.61

Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci (1998) 1.61

Reactivation of silent rRNA genes by simian virus 40 in human-mouse hybrid cells. Proc Natl Acad Sci U S A (1979) 1.58

Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect Immun (1997) 1.58

Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc Natl Acad Sci U S A (1992) 1.54

Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature (1995) 1.54

Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology (2007) 1.53

Stigmatization and shame: consequences of caring for HIV/AIDS patients in China. AIDS Care (2007) 1.53

Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells. Am J Transplant (2013) 1.52

Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation. Proc Natl Acad Sci U S A (1987) 1.52

Characterization and biological activity of cloned simian virus 40 DNA fragments. J Biol Chem (1981) 1.51

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

A stereoselective cobalt-containing nitrile hydratase. Biochemistry (1997) 1.46

Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res (2001) 1.46

Massive reduction in methicillin resistance by transposon inactivation of the normal PBP2 in a methicillin-resistant strain of Staphylococcus aureus. Microb Drug Resist (1997) 1.45

Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol (1998) 1.44

In vivo identification of the transforming gene product of simian sarcoma virus. Science (1982) 1.44

Coronary artery fistulae. Am J Med Sci (2006) 1.44

Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene (2007) 1.44

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy. Prostate Cancer Prostatic Dis (2012) 1.42

Structural organization and nucleotide sequence of mouse c-myb oncogene: activation in ABPL tumors is due to viral integration in an intron which results in the deletion of the 5' coding sequences. Nucleic Acids Res (1986) 1.42

Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Oncogene (1992) 1.42

Contribution of endogenously expressed Trp1 to a Ca2+-selective, store-operated Ca2+ entry pathway. FASEB J (2001) 1.41

The X-ray crystal structure of the Trichoderma reesei family 12 endoglucanase 3, Cel12A, at 1.9 A resolution. J Mol Biol (2001) 1.41

Unconventional gap state of trapped exciton in lead sulfide quantum dots. Nanotechnology (2010) 1.41

High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene (1999) 1.40

p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase. Oncogene (2000) 1.39

Attenuation of esophageal shortening during peristalsis with hiatus hernia. Gastroenterology (1995) 1.39

Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal. J Cell Biol (1999) 1.38

Allergy and risk of glioma: a meta-analysis. Eur J Neurol (2010) 1.38

Admixture and population stratification in African Caribbean populations. Ann Hum Genet (2006) 1.37

Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science (1990) 1.37

Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells. Oncogene (2009) 1.35

Optimized expression of green fluorescent protein in Toxoplasma gondii using thermostable green fluorescent protein mutants. Mol Biochem Parasitol (2001) 1.35

Complete amino acid sequence of human ornithine decarboxylase deduced from complementary DNA. DNA (1987) 1.32

Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation. Proc Natl Acad Sci U S A (1987) 1.31

AFM imaging of bacteria in liquid media immobilized on gelatin coated mica surfaces. Ultramicroscopy (2003) 1.31

Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30

Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription. Proc Natl Acad Sci U S A (1990) 1.28